Global Anthrax Treatment Market Size & Outlook, 2025-2033


Global Anthrax Treatment Market Insights

  • As per Reed Intelligence insights, the Global Anthrax Treatment Market stood at USD 422.56 Million in 2024 and is anticipated to grow to USD 678.64 Million by 2033.
  • The Global market is expected to advance at a CAGR of 5.5% from 2026 through 2033.
  • In 2024, Cutaneous Anthrax accounted for the highest share of the By Disease Type market size.
  • During the forecast period, Injection Anthrax is set to register the highest growth, making it the most lucrative By Disease Type segment.

Other Key Findings


  • United States is projected to lead the global Anthrax Treatment Market size by 2033.
  • Across Global, North America is anticipated to hold the dominant position in market size by 2033.
  • Europe is forecasted to expand at the fastest pace in Global, attaining USD 160.66 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 422.56 Million
Market Size In 2033 USD 678.64 Million
Largest segment Cutaneous Anthrax
Units Revenue in USD Million
CAGR 5.5% (2025-2033)
Segmnetation Covered
Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Middle East and Africa
  5. LATAM
By Disease Type
  1. Cutaneous Anthrax
  2. Inhalation Anthrax
  3. Gastrointestinal Anthrax
  4. Injection Anthrax
By Treatment Type
  1. Antibiotics
  2. Immunoglobulins
  3. Others
By Route of Administration
  1. Parenteral
  2. Oral
By End-User
  1. Hospitals
  2. Clinics
  3. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports